Skip to content
Company Analysis

Lantheus Holdings, Inc. LNTH

A comprehensive view of key metrics, scores, and financial health for Lantheus Holdings, Inc.

Overview of Lantheus Holdings, Inc.

LNTH NGM
Healthcare Drug Manufacturers - Specialty & Generic Framework: Pharma / Mature Biotech Mid Cap
Lantheus Holdings, Inc. (LNTH), is a Mid Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $107.95, about 50.7% overvalued vs fair value, +50.3% 1Y return, placing in the top 25% of its sector.
Metrics P/E 19.5× Rev Growth 0.5% ROE 21.5% Gross Margin 61.1%
USD 107.95
3.40%
(Delayed)
• Vol 90d: 35.8%
52-Week Range
Market Cap
$6.90B
Enterprise Value
$7.03B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Good
Efficiency
Good
Valuation
Good
Growth
Fair
Profitability
Good
Health
Good
Efficiency
Good
Valuation
Good
Completeness: 82%
Confidence: 85%
Updated: Jul 5
Top Beats

Quick Facts

Website https://www.lantheus.com
HQ Bedford, MA
Employees 1,193
Fiscal year Dec 31

Next Events

Earnings Aug 5 Estimated

Fair Value Snapshot

Bear Base Bull
$49
$53
$58
Current: $107.95 -51% vs base

Engine Room Money Flow™

Mid Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$1.5B
0.5%%
Gross Profit
$942.0M
-4.7%%
R&D Expense
$177.3M
5.5%%
Operating Income (EBIT)
$333.5M
-26%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

Cash Conversion
117.0%
Excellent

Strong cash conversion - profit becomes cash

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
3
Active Leaks
1/3
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Lantheus Holdings, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
68
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Moderate
55
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 97% Coverage
Trade-Off Triangle Visualization A ternary plot showing LNTH's balance between Growth (27.8%), Profitability (39.1%), and Safety (33.1%). Growth 28% Safety 33% Profitability 39%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

55th percentile vs peers
56
Key Signals
Revenue CAGR 3Y 18.1% 78p EPS CAGR 3Y 1.05 97p Rev Growth YoY 0.5% 38p EPS Growth YoY -21.7% 22p
Strengths
  • EPS CAGR 3Y in top 20% of peers (1.05, 97th percentile)
  • Interest Coverage Ratio in top 20% of peers (16.89, 91th percentile)
  • Superior capital returns - 3 return metrics above peer median
Risks

No significant risks identified for this axis.

Profitability

78th percentile vs peers
78
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

66th percentile vs peers
66
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Lantheus Holdings, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$53.21
- - -
-50.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000